Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer ’ s disease biomarkers
@inproceedings{Liu2015BioanalyticalAT, title={Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer ’ s disease biomarkers}, author={A. Liu}, year={2015} }
Alzheimer’s Disease (AD) is a complex neurological disorder affecting an increasing number of people worldwide. The amyloid hypothesis is the most widely accepted theory for the cause of AD and states that the main origin of the disease stems from the mis-folding and accumulation of the amyloid-beta peptide (Aβ). There is currently no cure for the disease, however, drugs are available to mitigate the symptoms. Multi-target directed ligands (MTDLs) have been implemented as a novel drug design… Expand
Figures from this paper
References
SHOWING 1-10 OF 171 REFERENCES
sym-Triazines for directed multitarget modulation of cholinesterases and amyloid-β in Alzheimer's disease.
- Chemistry, Medicine
- ACS chemical neuroscience
- 2013
- 21
- Highly Influential
Biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of Alzheimer's disease.
- Chemistry, Medicine
- ACS chemical neuroscience
- 2013
- 13
Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 2011
- 56
Multi-target-directed ligands in Alzheimer's disease treatment.
- Chemistry, Medicine
- Current medicinal chemistry
- 2011
- 173
Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 2008
- 164
Disease-modifying treatments for Alzheimer’s disease
- Medicine
- Therapeutic advances in neurological disorders
- 2011
- 109
- PDF
Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease
- Chemistry, Medicine
- Medicinal research reviews
- 2013
- 310
- PDF
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.
- Chemistry, Medicine
- Pharmacology & therapeutics
- 2007
- 236
Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.
- Biology, Medicine
- Annual review of pharmacology and toxicology
- 2003
- 791